Evidence map›Paper›PMID 37041138›Full record

ArticleNature communications2023

Enhancer hijacking at the ARHGAP36 locus is associated with connective tissue to bone transformation.

Uirá Souto Melo, Jerome Jatzlau, Cesar A Prada-Medina, Elisabetta Flex, Sunhild Hartmann, Salaheddine Ali, Robert Schöpflin, Laura Bernardini, Andrea Ciolfi, M-Hossein Moeinzadeh and 18 more

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets.International journal of biological sciences · 2025
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 5 countries.

Uirá Souto MeloMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany. umelo@molgen.mpg.de.ORCID http://orcid.org/0000-0003-4065-8635
Jerome JatzlauFreie Universität Berlin, Institute for Chemistry and Biochemistry, 14195, Berlin, Germany.
Cesar A Prada-MedinaMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.
Elisabetta FlexIstituto Superiore di Sanità, Department of Oncology and Molecular Medicine, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-6802-1356
Sunhild HartmannMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.
Salaheddine AliMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0002-0351-1645
Robert SchöpflinMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.
Laura BernardiniCytogenetics Unit, Casa Sollievo della Sofferenza Foundation, IRCCS, 71013, San Giovanni Rotondo, Foggia, Italy.
Andrea CiolfiMolecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID http://orcid.org/0000-0002-6191-0978
M-Hossein MoeinzadehMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, 14195, Berlin, Germany.
Marius-Konstantin KleverMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.
Aybuge AltayMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0001-7341-7091
Pedro Vallecillo-GarcíaFreie Universität Berlin, Institute for Chemistry and Biochemistry, 14195, Berlin, Germany.
Giovanna CarpentieriMolecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Massimo DelledonneDepartment of Biotechnology, University of Verona, 37129, Verona, Italy.ORCID http://orcid.org/0000-0002-7100-4581
Melanie-Jasmin OrtFreie Universität Berlin, Institute for Chemistry and Biochemistry, 14195, Berlin, Germany.
Marko SchwestkaInstitute of Active Polymers, Helmholtz-Zentrum Hereon, 14513, Teltow, Germany.
Giovanni Battista FerreroDepartment of Clinical and Biological Sciences, University of Torino, 10043, Torino, Italy.
Marco TartagliaMolecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.ORCID http://orcid.org/0000-0001-7736-9672
Alfredo BruscoDepartment of Medical Sciences, University of Torino, 10126, Torino, Italy.ORCID http://orcid.org/0000-0002-8318-7231
Manfred GossenInstitute of Active Polymers, Helmholtz-Zentrum Hereon, 14513, Teltow, Germany.
Dirk StrunkCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), 5020, Salzburg, Austria.ORCID http://orcid.org/0000-0003-1810-867X
Sven GeißlerJulius Wolff Institute (JWI), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.ORCID http://orcid.org/0000-0002-8750-6324
Stefan MundlosMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0002-9788-3166
Sigmar StrickerFreie Universität Berlin, Institute for Chemistry and Biochemistry, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0002-7174-5363
Petra KnausFreie Universität Berlin, Institute for Chemistry and Biochemistry, 14195, Berlin, Germany.ORCID http://orcid.org/0000-0003-2492-1667
Elisa GiorgioDepartment of Molecular Medicine, University of Pavia, 27100, Pavia, Italy. elisa.giorgio@unipv.it.
Malte SpielmannMax Planck Institute for Molecular Genetics, Development and Disease Group, 14195, Berlin, Germany. malte.Spielmann@uksh.de.
Max Planck Institute for Molecular Genetics · DEFreie Universität Berlin · DEBambino Gesù Children's Hospital · ITBerlin-Brandenburger Centrum für Regenerative Therapien · DEAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECasa Sollievo della Sofferenza · ITInstitute of Human Genetics · PLIstituto Superiore di Sanità · ITParacelsus Medical University · ATUniversity Hospital Schleswig-Holstein · DEUniversity of Pavia · ITUniversity of Turin · ITUniversity of Verona · IT

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
NHGRI Genome Sequencing Program Coordinating CenterU24HG008956 · NHGRI · RUTGERS, THE STATE UNIV OF N.J. · PI BUYSKE, STEVEN G, MATISE, TARA C. · 2016 to 2020
$4.9M
NHGRI NIH HHS U24 HG008956NHGRI NIH HHS U54 HG006542NHGRI NIH HHS UM1 HG006493
6 · The paper itself

Abstract

Heterotopic ossification is a disorder caused by abnormal mineralization of soft tissues in which signaling pathways such as BMP, TGFβ and WNT are known key players in driving ectopic bone formation. Identifying novel genes and pathways related to the mineralization process are important steps for future gene therapy in bone disorders. In this study, we detect an inter-chromosomal insertional duplication in a female proband disrupting a topologically associating domain and causing an ultra-rare progressive form of heterotopic ossification. This structural variant lead to enhancer hijacking and misexpression of ARHGAP36 in fibroblasts, validated here by orthogonal in vitro studies. In addition, ARHGAP36 overexpression inhibits TGFβ, and activates hedgehog signaling and genes/proteins related to extracellular matrix production. Our work on the genetic cause of this heterotopic ossification case has revealed that ARHGAP36 plays a role in bone formation and metabolism, outlining first details of this gene contributing to bone-formation and -disease.

Indexed as

Hedgehog ProteinsOssification, HeterotopicConnective TissueFemaleGTPase-Activating ProteinsHumansSignal TransductionTransforming Growth Factor betaARHGAP36 protein, humanGTPase-Activating ProteinsHedgehog ProteinsTransforming Growth Factor beta

Identifiers

PMID37041138
PMCPMC10090176
OpenAlexW4364380438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.